The Starch Solution (53 page)

15
. Felton CV, Crook D, Davies MJ, Oliver MF. Dietary polyunsaturated fatty acids and composition of human aortic plaques.
Lancet.
1994 Oct 29; 344 (8931): 1195–96.

16
. Sanders TA, de Grassi T, Miller GJ, Humphries SE. Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism.
Am J Clin Nutr.
1999; 69: 220–25.

17
. Larsen LF, Bladbjerg EM, Jespersen J, Marckmann P. Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII.
Arterioscler Thromb Vasc Biol.
1997 Nov; 17 (11): 2904–9.

18
. Friedman M, Rosenman RH, Byers SO. Serum lipids and conjunctival circulation after fat ingestion in men exhibiting type-A behavior patterns.
Circulation.
1964 Jun; 29: 874–86.

19
. Friedman M, Byers SO, Rosenman RH. Effect of unsaturated fats upon lipemia and conjunctival circulation. A study of coronary-prone (pattern A) men.
JAMA.
1965 Sep 13; 193: 882–86.

20
. Kuo P, Whereat AF, Horwitz O. The effect of lipemia upon coronary and peripheral arterial circulation in patients with essential hyperlipemia.
Am J Med.
1959 Jan; 26 (1): 68–75.

21
. Natoli S and McCoy P. A review of the evidence: nuts and body weight.
Asia Pac J Clin Nutr.
2007; 16 (4): 588–97.

22
. Sacks FM, Lichtenstein A, Van Horn L, et al; American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.
Circulation.
2006 Feb 21; 113 (7): 1034–44.

23
. Cassileth BR and Vickers AJ. Soy: an anticancer agent in wide use despite some troubling data.
Cancer Invest.
2003; 21 (5): 817–18.

24
. Lu L. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction.
Cancer Epidemiol Biomarkers Prev.
1996 Jan; 5 (1): 63–70.

25
. Divi R. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action.
Biochem Pharmacol.
1997 Nov 15; 54 (10): 1087–96.

26
. Doerge DR and Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones.
Environ Health Perspect.
2002 Jun; 110 Suppl 3: 349–53.

27
. Yellayi S. The phytoestrogen genistein induces thymic and immune changes: a human health concern?
Proc Natl Acad Sci USA.
2002 May 28; 99 (11): 7616–21.

28
. Zoppi G. Immunocompetence and dietary protein intake in early infancy.
J Pediatr Gastroenterol Nutr.
1982; 1 (2): 175–82.

29
. Zoppi G. Gammaglobulin level and soy-protein intake in early infancy.
Eur J Pediatr.
1979 Apr 25; 131 (1): 61–9.

30
. Zoppi G. Diet and antibody response to vaccinations in healthy infants.
Lancet.
1983 Jul 2; 2 (8340): 11–14.

31
. Fort P. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children.
J Am Coll Nutr.
1990 Apr; 9 (2): 164–67.

32
. Alexandersen P. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001 Mar 21; 285 (11): 1482–88.

33
. White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption.
J Am Coll Nutr.
2000 Apr; 19 (2): 242–55.

34
. Reddy ST. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism.
Am J Kidney Dis.
2002 Aug; 40 (2): 265–74.

35
. Jenkins DJ, Kendall CW, Vidgen E, et al. Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women.
Eur J Clin Nutr.
2003 Feb; 57 (2): 376–82.

36
. Yu H. Role of the insulin-like growth factor family in cancer development and progression.
J Natl Cancer Inst.
2000 Sep 20; 92 (18): 1472–89.

37
. Bartke A, Chandrashekar V, Dominici F, et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights.
Biogerontology.
2003; 4 (1): 1–8.

38
. Miller RA. Genetic approaches to the study of aging.
J Am Geriatr Soc.
2005 Sep; 53 (9 Suppl): S284–86.

39
. Holzenberger M. The GH/IGF-I axis and longevity.
Eur J Endocrinol.
2004 Aug; 151 Suppl 1: S23–7.

40
. Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs.
Science.
2007 Apr 6; 316 (5821): 112–15.

41
. Samaras TT, Elrick H, Storms LH. Is height related to longevity?
Life Sci.
2003 Mar 7; 72 (16): 1781–1802.

42
. Siegel-Itzkovich J. Health committee warns of potential dangers of soya.
BMJ.
2005 Jul 30; 331 (7511): 254.

43
. Turck D. Soy protein for infant feeding: what do we know?
Curr Opin Clin Nutr Metab Care.
2007 May; 10 (3): 360–65.

44
.
www.wholesoystory.com/newsletters/FrenchWARNING.pdf

45
.
www.babycareadvice.com/babycare/general_help/article.php?id=43

Chapter 11. Just to Be on the Safe Side: Don’t Take Supplements

1
. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Cochrane Database Syst Rev.
2008 Apr 16; (2): CD007176.

2
. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers.
Cochrane Database Syst Rev.
2008 Jul 16; (3): CD004183.

3
. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates?
Nature.
1981 Mar 19; 290 (5803): 201–8.

4
. Bjelke E. Dietary vitamin A and human lung cancer.
Int J Cancer.
1975 Apr 15; 15 (4): 561–65.

5
. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.
N Engl J Med.
1994 Apr 14; 330 (15): 1029–35.

6
. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
N Engl J Med.
1996 May 2; 334 (18): 1150–55.

7
. Pietrzik K. Antioxidant vitamins, cancer, and cardiovascular disease.
N Engl J Med.
1996 Oct 3; 335 (14): 1065–66.

8
. Bjelakovic G and Gluud C. Vitamin and mineral supplement use in relation to all-cause mortality in the Iowa Women’s Health Study.
Arch Intern Med.
2011 Oct 10; 171 (18): 1633–34.

9
. Redberg RF. Vitamin supplements: more cost than value: comment on “dietary supplements and mortality rate in older women.”
Arch Intern Med.
2011 Oct 10; 171 (18): 1634–35.

10
. Lee JE and Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention.
Gastroenterology.
2011 Jul; 141 (1): 16–20.

11
. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA.
2009; 301: 39–51.

12
. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA.
2011 Oct 12; 306 (14): 1549–56.

13
. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet.
2002 Jul 6; 360 (9326): 23–33.

14
. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
Lancet.
1997 Jun 14; 349 (9067): 1715–20.

15
. Mursu J, Robien K, Harnack LJ, et al. Dietary Supplements and Mortality Rate in Older Women: The Iowa Women’s Health Study.
Arch Intern Med.
2011 Oct 10; 171 (18): 1625–33.

16
. Lonn E, Bosch J, Yusuf S, et al; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
JAMA.
2005 Mar 16; 293 (11): 1338–47.

17
. Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting.
N Engl J Med.
2004 Jun 24; 350 (26): 2673–81.

18
. Bonaa KH, Njolstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
N Engl J Med.
2006 Apr 13; 354 (15): 1578–88.

19
. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
JAMA.
2008 May 7; 299 (17): 2027–36.

20
. Durga J, Bots ML, Schouten EG, et al. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults.
Am J Clin Nutr.
2011 May; 93 (5): 941–49.

21
. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, et al. Effects of homocysteine-lowering with folic acid plus vitamin vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
JAMA.
2010 Jun 23; 303 (24): 2486–94.

22
. House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.
JAMA.
2010 Apr 28; 303 (16): 1603–9.

23
. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral Vitamin D and falls and fractures in older women: a randomized controlled trial.
JAMA.
2010 May 12; 303 (18): 1815–22.

24
. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial.
JAMA.
2002 Aug 14; 288 (6): 715–21.

Vitamin D References:

25
. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes.
Ann Intern Med.
2010 Mar 2; 152 (5): 307–14.

26
. Grey A, Bolland MJ, Reid IR. Vitamin D supplementation.
Arch Intern Med.
2010 Mar 22; 170 (6): 572–73.

27
. Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited.
J Internal Med.
2000; 247: 260–68.

28
. Holick MF. Vitamin D: a millenium perspective.
J Cell Biochem.
2003; 88: 296–307.

29
. Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?
Prog Biophys Mol Biol.
2006 Sep; 92 (1): 9–16.

30
. Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population.
Horm Metab Res.
2009 May; 41 (5): 402–7.

31
. Salamone LM, Dallal GE, Zantos D, et al. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women.
Am J Clin Nutr.
1994 Jan; 59 (1): 80–86.

32
. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.
Am J Clin Nutr.
1999; 69: 84256.

33
. Holick MF. Sunlight Dilemma: risk of skin cancer or bone disease and muscle weakness.
Lancet.
2001; 357: 46.

34
. Wolpowitz D and Gilchrest BA. The vitamin D questions: how much do you need and how should you get it?
J Am Acad Dermatol.
2006 Feb; 54 (2): 301–17.

35
. Lucas RM, Repacholi MH, McMichael AJ. Is the current public health message on UV exposure correct?
Bull World Health Organ.
2006 Jun; 84 (6): 485–91.

36
. Wharton JR and Cockerell CJ. The sun: a friend and enemy.
Clin Dermatol.
1998 Jul-Aug; 16 (4): 415–19.

37
. Porojnicu A, Robsahm TE, Berg JP, Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D.
J Steroid Biochem Mol Biol.
2007 Mar; 103 (3-5): 675–78.

38
. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3
from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).
Cancer Causes Control.
2004 Mar; 15 (2): 149–58.

39
. Zhou W, Suk R, Liu G, et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients.
Cancer Epidemiol Biomarkers Prev.
2005 Oct; 14 (10): 2303–9.

40
. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma.
J Natl Cancer Inst.
2005 Feb 2; 97 (3): 195–99.

41
. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.
Am J Clin Nutr.
2004 Mar; 79 (3): 362–71.